Summary. The red cells of 63 members of 11 families were tested with 125I-labeled anti-Rh0(D). Families with a history of hemolytic disease of the newborn due to fetomaternal Rh incompatibility were selected for study. In such families it was possible to determine the antibody binding to the Rho(D) heterozygous red cells of the children and to compare within each family this value with the antibody bound to the father's Rh0(D)-positive red cells and the mother's Rh0(D)-negative red cells. The fathers in all the families studied could be assigned to two classes on the basis of the quantity of antibody bound to their red cells. One group bound about the same quantity of antibody to their cells as did their children, indicating that they were heterozygous for the Rho(D) antigen. The other bound about twice as much antibody to their cells as did their children, indicating that they were homozygous for the antigen. The Rh genotype of the father in all 11 families could be ascertained by using the children in each family as a reference point. The members of two families showed a poor correspondence between antibody binding and zygosity. In one family an Rh heterozygous child (R1r) took up 85% of the antibody bound to the father's homozygous cells (R'R'), and in the other family an Rh heterozygous child (R1r) took up 20% more antibody than did the cells of her father, which were of the same Rh phenotype (Rh,) and zygosity. 
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The quantity of antibody bound to the red cells of unrelated Rho(D) homozygous individuals of the same Rh phenotype (Rh1) showed an almost sixfold variation. A consequence of this observation was that the cells of Rho(D) heterozygous children of high antibody uptake fathers took up more antibody than did the cells of low antibody uptake Rho(D) homozygous fathers. The gene dosage effect for the Rho(D) antigen demonstrable within a family does not appear to apply when unrelated individuals are tested, even though they may be of the same Rh phenotype.
Introduction
Many serological and isotopic studies (1) (2) (3) (4) (5) have shown that a complex relationship exists between the red cell Rho(D) antigen content and the donor's genotype. Conventional serological were tested with 131I-labeled anti-Rh0 (D). The frequency distribution of the amount of antiRh0 (D) bound to the red cells derived from this population was analyzed. Only those Rho(D)-positive red cell types that did not contain the rh'(C) antigenic determinant segregated into two populations. There was a 1.6-fold difference between the means of the two populations, suggesting that the two red cell populations represented the Rh0o(D) heterozygous and homozygous states.
Red cells containing the rh'(C) antigenic determinant did not show the expected bimodal distribution.
The improvement in techniques that has occurred since the previous report and the identification of some of the factors (8, 9) that affect the reaction between the red cell and the anti-Rho(D) encouraged us to re-examine the relationship between genotype and red cell Rh0o(D) antigen content.
The present study differs from the previous report (3) in a number of important respects. The red cells examined in this study were obtained from the members of families in which there was a history of hemolytic disease of the newborn due to fetomaternal Rho(D) incompatibility. In such families the Rho(D) heterozygous state was represented by the Rho(D)-positive red cells of the children. We chose these families to ascertain the heterozygous state and not to study the factors involved in producing erythroblastosis.
Each sample of red cells was tested with different concentrations of antibody so that the optimal proportion of cells to antibody was experimentally determined. Previously (3) the cells were tested at only one antibody concentration, which, for some cells, may have been insufficient to establish equilibrium and, for other cells, may have been in sufficient antibody excess to produce inhibition of antibody binding (10) . The antibody bound to the red cells is presented in terms of red cell numbers rather than, as previously, in terms of red cell volume determined by centrifugation. Presentation of the results in this form avoids introducing into the data any differences that may be due to variations in the red cell volumes among the different donors. Finally, the 125I-labeled anti-Rho(D) used in the present study was derived from a gamma G fraction obtained by DEAE chromatography rather than from a crude gamma G fraction contaminated with other plasma proteins (11 6 Ror (cDe/cde), 3 R2r (cDE/cde), 2 R'r' (CDe/Cde), 1 R°R°(cDe/cDe), 1 R1R' (CDe/cDE), and 1 R2R' (cDE/cDE). The probable Rh genotypes of the 11 fathers included above were 6 R'R1, 2 R'r, and 1 each of R°R°, R1R2, and R2R2. All the families were Caucasian except family Br, which was Negro.
Fourteen of the 41 children were treated by exchange transfusion one or more times. In 6 of the 11 families there were fetal or neonatal deaths due to Rh incompatibility. The children in 2 families were only mildly affected and did not require exchange transfusions.
The family data are summarized in Table I . The probable Rh genotype of the members of these families was assigned on the basis of the family data (unequivocally in those families with Rho(D) -negative children).
The isotopic methods described previously (3, 13) were used except for the procedures described below.
Fraction of the anti-Rho (D) serum. REZ serum was obtained from a 34-year-old group 0, rr Caucasian housewife who delivered an 0, R1r (CDe/cde) infant with hemolytic disease in 1954. She had a Fallopian tube ligation and subsequently was reimmunized on four occasions between 1961 and 1964 by intravenous administration of 2 ml of whole blood from two different 0, R°( cDe) donors. Three different globulin preparations obtained from her serum were used for these studies. Globulin preparation A-79 was obtained by ethodin (Rivanol) fractionation (14) and preparations A-87 and A-88 by DEAE chromatography using the technique of Levy and Sober (15) . The globulin preparations were trace labeled with "I using iodine monochloride (16).
1The results are presented as probable Rh genotypes (in italics) rather than phenotypes. The genotype assignment is based on the family data. As will be evident from the results, the data obtained in this study do not favor or support any of the three Rh nomenclatures in current use (6, 7, 12) . Table II .
Preparation of eluates containing .5I-labeled-Rho (D). The heat eluate derived from preparation A-79 was obtained by sensitizing a pool of lyophilized D-positive red cell stromata with the 'I-labeled globulin fraction at 370 C for 90 minutes. The sensitized stromata were washed four times and eluted by using the techniques described previously (3, 13) . A total of 80 g of stromata derived from a pool consisting of 34 U of Rho(D)-positive red cells was used, and 0.31 mg globulin nitrogen per g of lyophilized stromata was used for sensitization.
The eluates obtained from the gamma G--15I preparations A-87 and A-88 were derived from sensitized intact red cells. A pool composed of 16 U of R' (CDe) and R' (cDE) red cells was used for A-87, and a 9-U pool was used for A-88. The red cells were sensitized with the gamma G-S'I at 370 C for 90 minutes by using 2.78 mg A-87 globulin nitrogen and 2.81 mg A-88 globulin nitrogen per 200 ml of packed red cells. The sensitized cells were washed and converted to stromata by freezing and thawing three times after the addition of 1 vol of buffered isotonic saline, pH 6.5, containing 2% bovine serum albumin (BSA). The stromata were recovered by centrifugation in the Spinco model L at 73,000 maximal g for 15 minutes and washed by centrifugation four times with buffered isotonic saline, pH 6.5, containing 0.1%o BSA.
The washed sensitized stromata derived from preparation A-87 were divided into two equal portions. One was eluted with heat, 560 C for 20 minutes, using pH 5.8, 0.15 M phosphate buffer containing 0.03% carrier human gamma G. The other portion of sensitized stromata as well as the A-88 sensitized stromata was eluted with acid. The stromata were suspended in saline containing 2% BSA, and the pH was gradually lowered at 230 C to pH 3.2 using 0.2 N HC1. After adjustment of the pH, the supernatant containing the eluted 'SI-labeled anti-Rho(D) was recovered by centrifugation and adjusted to pH 6.5 with 0.2 N NaOH. The anti-Rho(D) was exposed to pH 3.2 for 20 to 30 minutes by this technique.
All eluates were concentrated six-to eightfold with polyethylene glycol (Carbowax), and the concentrated eluates were readjusted to pH 6.5 by dialysis against buffered isotonic saline, pH 6.5, , = 0.16. The nitrogen content of the four anti-Rho(D)-containing eluates ranged from 0.571 to 0.080 ,ug nitrogen per ml. The eluate nitrogen was calculated from the 'I content of the eluates and the I to nitrogen ratio of the anti-Rho(D)-containing gamma G fraction. The nitrogen content of the gamma G fraction was determined by the micro-Kjeldahl method (17) . The anti-Rho(D) titers with the antiglobulin reaction ranged from 16 to 32. The original REZ serum had an anti-rh' (C) titer of 1: 8, but the eluates were (24) (25) (26) . The equilibrium value represents the amount of cell-bound anti-Rho(D) under the conditions of reaction used for testing the cells; pH, ionic strength, time, temperature, proportion of cells to antibody, and so forth. The cell-bound nitrogen under the conditions of reaction used in this study (equilibrium value) was about 80% of the extrapolated value. The assumptions involved in converting radioactivity to nitrogen have been discussed previously (3, 11, 13) .
We facilitated data processing by transcribing the data from the automatic counter directly onto IBM cards by coupling an IBM 526 card punch summary to the counter. The data on the IBM cards were processed by using an IBM 1620 or 1401 computer and a program designed for these studies.
Results
Cell-bound 125I-labeled anti-Rho(D) at equi- homozygous fathers such as in the Br family in )n the anti- Figure 1 and the Go family in Figure 3, Figure 2 , about the same 125I-labeled quantity of antibody is bound to the red cells of the maximal the father and his children. The relationship bemurred when tween the father and his children with respect to s cell-bound, antibody uptake appears to be maintained at all 3s was maxi-concentrations of added eluate nitrogen ( Figures  1 and 3) . The data for all the red cells tested in this study were graphically analyzed by using the Scatchard equation, as in Figure 4 , to obtain an estimate of the total antibody required to satu- A87 (Table IV) . Table III show that when the ionic strength of the reaction medium was reduced from 0.26 to 0.12, there was about a 2.5-fold increase in the equilibrium value of cell-bound anti-Rh, (D) . The increased binding at low ionic strength was proportional to the binding at high ionic strength, so that the relationship between the father's red cells and those of his children was maintained at either ionic strength (see last two columns, Table III) .
Results obtained with different 121I-labeled antiRho (D)-containing eluates. Members of the Br family were tested on different dates with two heat eluates derived from two different globulin preparations, A-79 and A-87. The two preparations differed in many major respects (see Table  II ). Globulin fraction A-79 was a crude gamma G obtained by ethodin fractionation contaminated with albumin, transferrin, and other proteins. Globulin fraction A-87 was a homogeneous gamma G preparation obtained by DEAE chromatography. The A-79 eluate was obtained after sensitization of lyophilized stromata, whereas the A-87 eluate was obtained after sensitization of fresh intact red cells. In spite of these differences in the preparation of the two eluates, the relationship between the father and his children with respect to quantity of cell-bound anti-Rho ( D) was al- The families included in the study were not selected at random. They were identified and included in the study because there had been a history of clinically significant hemolytic disease of the newborn due to Rh incompatibility. The degree of selection involved in using such a population is evident from the fact that only 2 to 5%o of Rh-incompatible pregnancies result in hemolytic disease (30) . Consequently, the families used for this study may differ from the general population with respect to the Rh0o(D) antigen. The families also differed among themselves with respect to another factor involved in maternal Rh sensitization. There is good evidence to indicate that fetomaternal incompatibility in the ABO blood group system protects against primary maternal Rh sensitization (31, 32) . Two families in the present study had such fetomaternal incompatibility in the ABO antigens. The type 0 mothers in the Br and Th families had type A children. Only one of the A children in the Th family had mild disease, since all the children were A and incompatible with their 0 mother. The first three children in the Br family, however, were 0 and compatible with their 0 mother, so that the mother was sensitized to the Rh0o(D) antigen. The ABO incompatibility of the last three A children did not protect the children in the Br family because the mother had been sensitized by previous ABO-compatible pregnancies. There was no evidence that these two families with ABO incompatibility were different from the other families with respect to the amount of red cell-bound anti-
Rho (D).
The antigenic strength of the Rh0 (D) antigen of fetal cells has been implicated as an important factor in producing hemolytic disease (33 (36) . If the degree of heterogeneity in different donors varied, the use of the average value for cell-bound anti-Rho(D) would be unreliable for comparing one donor to another.
The estimates of the Rh0o(D) antigen content of red cells made in the previous report (3) are in agreement with those in the present study. The values ranged from 4,600 to 10,300 Rho(D) sites per red cell, whereas in the present study the values varied from 3,500 to 36,700. Only three of the 49 Rh0 (D)-positive cells tested in this study had more than 11,000 sites per cell., This agreement between the two studies is fortuitous. The estimates in the earlier study (3) were subject to two errors of equal magnitude but opposite direction, which canceled each other and resulted in estimates that agree with the values found in this study. In the previous study the red cell antigen content was overestimated by using the iodine to nitrogen ratio of a globulin preparation (A-25) that was contaminated with albumin and other proteins differing from gamma G in their tyrosine contents (11) . This overestimation was compensated for by the underestimation that resulted from the use of the equilibrium value rather than the quantity of antibody that would be required to occupy all of the antigenic sites.
The values found in the present study are in the range reported by Rosenfield and Kochwa (29, 37) , but are less than the estimates obtained by Hughes-Jones and co-workers, who found 24,000 sites per cell with 131I-labeled anti-Rh0 (D) (24) and by Rochna and Hughes-Jones, who found from 10,000 to 33,000 sites per cell with 131I-labeled antigamma globulin (5) . In view of the many assumptions used in deriving these values, the values obtained in these different studies are in relatively good agreement.
Evidence was obtained to show that by using (36) .
The variability in strength of the Rh0o(D) antigen in different Rh phenotypes is well known (6, 7). There is weakening of the Rh0 (D) antigen when the rh'(C) antigen is present (1) (2) (3) (4) 20) . This effect is also found when an rh'(C)-positive Rh0 (D)-negative allele is paired with an Rh0 (D)-carrying allele (40, 41 
